MPPE1 and melanoma: The capacity of migratory cDC1 and cDC2 to cross-present antigen has been observed before in the steady state.42 However, it is not entirely understood what exactly is the role of the migratory skin DC subsets in the priming of melanoma-specific T cells and how this role changes in response to immunotherapy.